Sex hormone-binding globulin as an independent predictor of incident type 2 diabetes mellitus in men

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 65 A, Issue 5, 2010, Pages 503-509

  Lakshman, Kishore M ^a   Bhasin, Shalender ^a   Araujo, Andre B ^b  

^a BOSTON MEDICAL CENTER   (United States)

^b NEW ENGLAND RESEARCH INSTITUTES   (United States)

Author keywords

SHBG; Testosterone; Type 2 diabetes

Indexed keywords

SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGE; AGED; AGING; ARTICLE; BLOOD; BODY MASS; HUMAN; LONGITUDINAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; REGRESSION ANALYSIS; RISK FACTOR;

ADULT; AGE FACTORS; AGED; AGING; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; RISK FACTORS; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 77951892840     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glq002     Document Type: Article

References (51)

1. Haffner SM, Shaten J, Stern MP, Smith GD, Kuller L. Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MrFIT research Group. Multiple risk Factor Intervention Trial. Am J Epidemiol. 1996;143(9):889-897.
2. Stellato RK, Feldman HA, Hamdy O, Horton ES, McKinlay JB. Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care. 2000;23(4):490-494.
3. Oh J-Y, Barrett-Connor E, Wedick NM, Wingard DL. Endogenous sex hormones and the development of type 2 diabetes in older men and women: the rancho Bernardo Study. Diabetes Care. 2002;25(1):55-60.
4. Svartberg J, Jenssen T, Sundsfjord J, Jorde R. The associations of endogenous testosterone and sex hormone-binding globulin with glyco-sylated hemoglobin levels, in community dwelling men. The Tromso Study. Diabetes Metab. 2004;30(1):29-34.
5. Laaksonen DE, Niskanen L, Punnonen K, et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care. 2004;27(5):1036-1041.
6. Selvin E, Feinleib M, Zhang L, et al. Androgens and diabetes in men: results from the third National health and Nutrition examination Survey (NhANeS III). Diabetes Care. 2007;30(2):234-238.
7. Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2006;295(11):1288-1299.
8. Kapoor D, Aldred H, Clark S, Channer KS, Jones Th. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity. Diabetes Care. 2007;30(4):911-917.
9. Zhao JL, Chen ZJ, Zhao YR, et al. Study on the (TAAAA)n repeat polymorphism in sex hormone-binding globulin gene and the ShBG serum levels in putative association with the glucose metabolic status of Chinese patients suffering from polycystic ovarian syndrome in Shandong province. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2005;22(6):644-647.
10. Ding EL, Song Y, Manson JE, et al. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med. 2009; 361(12):1152-1163.
11. Basu R, Dalla Man C, Campioni M, et al. Effect of 2 years of testosterone replacement on insulin secretion, Insulin action, Glucose effectiveness, Hepatic insulin clearance, and postprandial glucose turnover in elderly men. Diabetes Care. 2007;30(8):1972-1978.
12. Jedrzejuk D, Medras M, Milewicz A, Demissie M. Dehydroepiandros-terone replacement in healthy men with age-related decline of DheA-S: effects on fat distribution, Insulin sensitivity and lipid metabolism. Aging Male. 2003;6(3):151-156.
13. Basu R, Dalla Man C, Campioni M, et al. Two years of treatment with dehydroepiandrosterone does not improve insulin secretion, Insulin action, or postprandial glucose turnover in elderly men or women. Diabetes. 2007;56(3):753-766.
14. Haddad RM, Kennedy CC, Caples SM, et al. Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc. 2007;82(1):29-39.
15. Corrales JJ, Burgo RM, Garca-Berrocal B, et al. Partial androgen def-ciency in aging type 2 diabetic men and its relationship to glycemic control. Metabolism. 2004;53(5):666-672.
16. Nair KS, Rizza RA, O'Brien P, et al. DheA in elderly women and DheA or testosterone in elderly men. N Engl J Med. 2006;355(16): 1647-1659.
17. O'Donnell AB, Araujo AB, McKinlay JB. The health of normally aging men: the Massachusetts Male Aging Study (1987-2004). Exp Gerontol. 2004;39(7):975-984.
18. US Census Bureau. Census of Population and housing, 1990: Summary Tape File 3 on CD-ROM/prepared by the Bureau of the Census. Washington, DC: The Bureau [producer and distributor]; 1992.
19. Sallis JF, Haskell WL, Wood PD, et al. Physical activity assessment methodology in the fve-city project. Am J Epidemiol. 1985;121(1): 91-106.
20. Khavari KA, Farber PD. A profle instrument for the quantifcation and assessment of alcohol consumption. The Khavari Alcohol Test. J Stud Alcohol. 1978;39(9):1525-1539.
21. Harlow SD, Linet MS. Agreement between questionnaire data and medical records. The evidence for accuracy of recall. Am J Epidemiol. 1989;129(2):233-248.
22. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84(10):3666-3672.
23. Fortunati N. Sex hormone-binding globulin: not only a transport protein. What news is around the corner? J Endocrinol Invest. 1999;22(3): 223-234.
24. Hryb DJ, Khan MS, Rosner W. Testosterone-estradiol-binding globulin binds to human prostatic cell membranes. Biochem Biophys Res Commun. 1985;128(1):432-440.
25. Krupenko SA, Krupenko NI, Danzo BJ. Interaction of sex hormone-binding globulin with plasma membranes from the rat epididymis and other tissues. J Steroid Biochem Mol Biol. 1994;51(1-2):115-124.
26. Kahn SM, Hryb DJ, Nakhla AM, Romas NA, Rosner W. Sex hormone-binding globulin is synthesized in target cells. J Endocrinol. 2002; 175(1):113-120.
27. Heinlein CA, Chang C. The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions. Mol Endocrinol. 2002;16(10):2181-2187.
28. Rosner W, Hryb DJ, Khan MS, Nakhla AM, Romas NA. Androgen and estrogen signaling at the cell membrane via G-proteins and cyclic adenosine monophosphate. Steroids. 1999;64(1-2):100-106.
29. Nakhla AM, Leonard J, Hryb DJ, Rosner W. Sex hormone-binding globulin receptor signal transduction proceeds via a G protein. Steroids. 1999;64(3):213-216. (Pubitemid 29283674)
30. Hammes A, Andreassen TK, Spoelgen R, et al. Role of endocytosis in cellular uptake of sex steroids. Cell. 2005;122(5):751-762.
31. Ring HZ, Lessov CN, Reed T, et al. Heritability of plasma sex hormones and hormone binding globulin in adult male twins. J Clin En-docrinol Metab. 2005;90(6):3653-3658.
32. Meikle AW, Stephenson RA, Lewis CM, et al. Age, Genetic, and non-genetic factors infuencing variation in serum sex steroids and zonal volumes of the prostate and benign prostatic hyperplasia in twins. Prostate. 1997;33(2):105-111.
33. Eriksson AL, Lorentzon M, Mellstrom D, et al. ShBG gene promoter polymorphisms in men are associated with serum sex hormone-binding globulin, Androgen and androgen metabolite levels, and hip bone mineral density. J Clin Endocrinol Metab. 2006;91(12):5029-5037.
34. Khosla S, Atkinson EJ, Dunstan CR, O'Fallon WM. Effect of estrogen versus testosterone on circulating osteoprotegerin and other cytokine levels in normal elderly men. J Clin Endocrinol Metab. 2002;87(4): 1550-1554.
35. Bellido T, Jilka RL, Boyce BF, et al. Regulation of interleukin-6, Osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor. J Clin Invest. 1995;95(6):2886-2895.
36. Kapoor D, Clarke S, Stanworth R, Channer KS, Jones TH. The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes. Eur J Endocrinol. 2007;156(5):595-602.
37. Lambert CP, Sullivan DH, Evans WJ. Effects of testosterone replacement and/or resistance training on interleukin-6, Tumor necrosis factor alpha, and leptin in elderly men ingesting megestrol acetate: a randomized controlled trial. J Gerontol A Biol Sci Med Sci. 2003;58(2): 165-170.
38. Malkin CJ, Pugh PJ, Jones RD, Kapoor D, Channer KS, Jones Th. The effect of testosterone replacement on endogenous infammatory cytokines and lipid profles in hypogonadal men. J Clin Endocrinol Metab. 2004;89(7):3313-3318.
39. Ng MK, Liu PY, Williams AJ, et al. Prospective study of effect of an-drogens on serum infammatory markers in men. Arterioscler Thromb Vasc Biol. 2002;22(7):1136-1141.
40. Singh AB, Hsia S, Alaupovic P, et al. The effects of varying doses of T on insulin sensitivity, Plasma lipids, Apolipoproteins, and C-reactive protein in healthy young men. J Clin Endocrinol Metab. 2002; 87(1):136-143.
41. Vincent A, Riggs BL, Atkinson EJ, Oberg AL, Khosla S. Effect of estrogen replacement therapy on parathyroid hormone secretion in elderly postmenopausal women. Menopause. 2003;10(2):165-171.
42. Maggio M, Basaria S, Ble A, et al. Correlation between testosterone and the infammatory marker soluble interleukin-6 receptor in older men. J Clin Endocrinol Metab. 2006;91(1):345-347.
43. Crave JC, Lejeune H, Brebant C, Baret C, Pugeat M. Differential effects of insulin and insulin-like growth factor I on the production of plasma steroid-binding globulins by human hepatoblastoma-derived (hep G2) cells. J Clin Endocrinol Metab. 1995;80(4):1283-1289.
44. Katsuki A, Sumida Y, Murashima S, et al. Acute and chronic regulation of serum sex hormone-binding globulin levels by plasma insulin concentrations in male noninsulin-dependent diabetes mellitus patients. J Clin Endocrinol Metab. 1996;81(7):2515-2519.
45. Pasquali R, Casimirri F, De Iasio R, et al. Insulin regulates testosterone and sex hormone-binding globulin concentrations in adult normal weight and obese men. J Clin Endocrinol Metab. 1995;80(2):654-658.
46. Plymate SR, Matej LA, Jones RE, Friedl KE. Inhibition of sex hormone-binding globulin production in the human hepatoma (hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab. 1988; 67(3):460-464.
47. Yki-Jarvinen H, Makimattila S, Utriainen T, Rutanen EM. Portal insulin concentrations rather than insulin sensitivity regulate serum sex hormone-binding globulin and insulin-like growth factor binding protein 1 in vivo. J Clin Endocrinol Metab. 1995;80(11): 3227-3232.
48. Birkeland KI, Hanssen KF, Torjesen PA, Vaaler S. Level of sex hormone-binding globulin is positively correlated with insulin sensitivity in men with type 2 diabetes. J Clin Endocrinol Metab. 1993; 76(2):275-278.
49. Muller M, Grobbee DE, den Tonkelaar I, Lamberts SW, van der Schouw YT. Endogenous sex hormones and metabolic syndrome in aging men. J Clin Endocrinol Metab. 2005;90(5):2618-2623. (Pubitemid 40686299)
50. Tsai EC, Matsumoto AM, Fujimoto W Y, Boyko EJ. Association of bioavailable, Free, and total testosterone with insulin resistance: infu-ence of sex hormone-binding globulin and body fat. Diabetes Care. 2004;27(4):861-868.
51. Osuna JA, Gomez-Perez R, Arata-Bellabarba G, Villaroel V. Relationship between BMI, Total testosterone, sex hormone-binding-globulin, Leptin, Insulin and insulin resistance in obese men. Arch Androl. 2006;52(5):355-361.